Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Oxygen-Supplying Piezocatalytic Therapy of Hypoxic Tumors by Intratumoral Delivery of pH-Responsive Multicompartmental Carriers with Sequential Drug Release Capability

Authors
Truong Hoang, QuanKim, Do YeonPark, Hyun SuJang, WookyoungNguyen Cao, Thuy GiangKang, Ji HeeKo, Young TagMun, Seok JoonBhang, Suk HoShim, Min SukBong, Ki Wan
Issue Date
May-2024
Publisher
WILEY-V C H VERLAG GMBH
Keywords
hypoxia; Janus particles; piezocatalytic cancer therapy; stop-flow lithography; zinc oxide nanorods
Citation
ADVANCED FUNCTIONAL MATERIALS, v.34, no.21
Journal Title
ADVANCED FUNCTIONAL MATERIALS
Volume
34
Number
21
URI
https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/91441
DOI
10.1002/adfm.202306078
ISSN
1616-301X
1616-3028
Abstract
Piezocatalytic cancer therapy, in which piezoelectric nanomaterials generate reactive oxygen species (ROS) via piezocatalytic redox reactions under mechanical stress, has emerged as an effective strategy for cancer treatment. However, the inherent hypoxia in tumor microenvironments enormously restricts its efficacy. To address this issue, acid-degradable Janus-type multicompartmental carriers able to separately encapsulate piezocatalytic gold nanoparticle-coated poly(ethylene glycol)-modified zinc oxide nanorods (Au@P-ZnO NRs) and O2-generating catalase (CAT) are fabricated in this study using stop-flow lithography (SFL). The CAT and Au@P-ZnO NRs are sequentially released by modulating the composition ratios of acid-cleavable monomers in the precursor solution during the SFL. The sequential release by the Janus carriers significantly increased the intracellular ROS levels under hypoxia conditions upon ultrasound irradiation owing to the O2 supplied by the CAT. An in vivo study showed that a single intratumoral injection of Janus particles encapsulating the CAT and Au@P-ZnO NRs efficiently alleviated tumor hypoxia and substantially suppressed tumor growth. This study demonstrates that pH-responsive, O2-generating, and piezocatalytic Janus carriers have high potential for piezocatalytic therapy of hypoxic tumors and offers insights into using pH-responsive Janus carriers for efficient hypoxia-relieving piezocatalytic cancer therapy via the cascade of oxygenation and ROS generation. pH-responsive Janus-type multicompartmental carriers encapsulating piezocatalytic Au@P-ZnO NRs and O2-generating natural catalase (CAT) in separate compartments are developed for ultrasound-triggered, hypoxia-relieving, tumor-targeted piezocatalytic therapy. The Janus carriers enable the sequential release of the CAT (Step I) and Au@P-ZnO NRs (Step II) under acidic tumor microenvironments and thus efficiently eradicate hypoxic tumors under ultrasound irradiation via the cascade of oxygenation and ROS generation.image
Files in This Item
There are no files associated with this item.
Appears in
Collections
ETC > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Ko, Young Tag photo

Ko, Young Tag
Pharmacy (Dept.of Pharmacy)
Read more

Altmetrics

Total Views & Downloads

BROWSE